Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Unavailable
    Antiprotozoal Drug Discovery: A Challenge That Remains
    Unavailable
    Antiprotozoal Drug Discovery: A Challenge That Remains
    Unavailable
    Antiprotozoal Drug Discovery: A Challenge That Remains
    Ebook298 pages3 hours

    Antiprotozoal Drug Discovery: A Challenge That Remains

    By Vearsa Limited

    ()

    Currently unavailable

    Currently unavailable

    About this ebook

    Protozoan infections that are endemic in countries with limited economic resources pose a significant public health challenge to affected communities and some of these diseases are categorized as neglected tropical diseases by the World Health Organization. At the moment, there is an urgent need to identify and develop new antiprotozoal drugs. Antiprotozoal Drug Discovery: A Challenge That Remains brings together research from all scientists (including parasitologists, chemists, biologists among others) involved in the field of antiprotozoal experimental pharmacology, drug design and natural product research. The monograph is a compilation of review chapters written by experts on medical parasitology and pharmacology that covers a wide range of topics such as general characteristics of protozoan diseases (malaria, toxoplasmosis, Chagas’ disease, leishmaniasis, trichomoniasis) prophylaxis, treatments, natural products and rational drug design. The contents of this book are useful to medical microbiologists and pharmaceutical scientists seeking to update their knowledge about antiprotozoal drug design.

    LanguageEnglish
    PublisherVearsa Limited
    Release dateSep 6, 2016
    ISBN9781681083292
    Unavailable
    Antiprotozoal Drug Discovery: A Challenge That Remains

    Related to Antiprotozoal Drug Discovery

    Related ebooks

    Medical For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Opinion: ‘One-and-done’ For New Drugs Could Cut Patent Thickets And Boost Generic Competition

      Feb 11, 2019

      Instead of patenting new drugs, companies are recycling old ones to build insurmountable patent walls. We can fix that with a "one-and-done" approach that gives each drug one, and only…

      4 min read

    • Article

      Will Congress Turn Its Back on the Safety of America’s Workers?

      Mar 16, 2017

      Let’s say someone you care about—mother, father, wife, husband, partner, son, daughter, friend, and neighbor—works in a facility that’s had a history of serious injuries or illnesses. You know, like burns, amputations, and broken bones that happen at

      3 min read

    • Article

      Dr. William Levine

      Jan 3, 2020

      Dr. William Levine
      5 min read

    • Article

      Opinion: The FDA Needs To Set Standards For Using Artificial Intelligence In Drug Development

      Nov 7, 2019

      Poorly constructed AI algorithms for drug discovery and testing have the potential to cause harm. The FDA should play an important role in ensuring that AI-based drug development tools meet…

      3 min read

    • Article

      Opinion: Manufacturing: The Next Breakthrough In Gene Therapy

      Dec 18, 2019

      As the race heats up to bring gene therapy to market, breakthroughs in manufacturing are often the key — or break down the barrier — to delivering these therapies to…

      3 min read

    • Article

      Opinion: Companies Must Responsibly Manufacture The Antimicrobials Society Needs

      Jan 30, 2020

      Providing access to antibiotics and other antimicrobials while reducing resistance to these medicines presents a dual manufacturing challenge: ensuring a cost-effective supply while minimizing their emission into the environment.

      4 min read

    • Article

      Know Exactly What Your Health Cover Insures You For

      Nov 14, 2020

      THE HEALTH-CARE environment in South Africa is a mess. On the one hand you have a collapsing state health system that can’t even get the basics right, such as hospital hygiene. On the other hand you have a private healthcare system that matches anyth

      2 min read

    • Article

      Opinion: A Quantum Of Innovation And The Incentives To Match

      Mar 7, 2019

      Modest tweaks to drugs, what some dismiss as "merely incremental," can represent real and compelling advances for patients and offer great value over time.

      9 min read

    • Article

      Know Exactly What Your Health Cover Insures You For

      Nov 14, 2020

      THE HEALTH-CARE environment in South Africa is a mess. On the one hand you have a collapsing state health system that can’t even get the basics right, such as hospital hygiene. On the other hand you have a private health-care system that matches anyt

      2 min read

    • Article

      The Rise of Risk-Mitigating Technologies

      Jan 1, 2021

      You have said the global pandemic is forcing firms to rethink their innovation strategies. Why is that? A major event like the pandemic changes consumers’ priorities, their preferences and their needs. As a result of COVID-19, people care a lot more

      6 min read

    • Article

      Opinion: Synthetic Control Arms Can Save Time And Money In Clinical Trials

      Feb 5, 2019

      Synthetic control arms aren't the solution to all of the challenges facing randomized trials, but they represent a great way for drug development companies to start using real-world evidence.

      4 min read

    • Article

      How SA Regulates Medicines And Vaccines

      Feb 13, 2021

      COVID-19 has raised public awareness about the role of national medicines regulatory authorities in enabling access to safe, effective and quality-assured medicines. This includes vaccines. In South Africa, the pandemic has also exposed several impor

      4 min read

    • Article

      How SA Regulates Medicines And Vaccines

      Feb 13, 2021

      COVID-19 has raised public awareness about the role of national medicines regulatory authorities in enabling access to safe, effective and quality-assured medicines. This includes vaccines. In South Africa, the pandemic has also exposed several impor

      4 min read

    • Article

      How SA Regulates Medicines And Vaccines

      Feb 13, 2021

      COVID-19 has raised public awareness about the role of national medicines regulatory authorities in enabling access to safe, effective and quality-assured medicines. This includes vaccines. In South Africa, the pandemic has also exposed several impor

      4 min read

    • Article

      Protect Your Farm With A Customised Employment Contract

      Dec 7, 2020

      Ansofie van der Walt. Labour law sets strict requirements and compliance is non-negotiable. Failure to comply also holds a serious business risk for employers that is often underestimated. An arbitration award against an employer can have a signific

      2 min read

    • Article

      Whathappenedto ‘Donoharm’?

      Nov 24, 2019

      I t’s confusing for a lot of people knowing that your doctors have signed up to a medical code of conduct—proposed 2,500 years ago by the Greek doctor and philosopher Hippocrates—that undertakes they must “First, do no harm.” Yet we also know that pr

      3 min read

    • Article

      What is Ethylene Oxide? Answers to Your Questions about the Cancer-Causing Chemical

      Oct 6, 2022

      How to find out if a facility near you is emitting ethylene oxide, what the risks are, and how you can get involved to protect public health

      4 min read

    • Article

      Opinion: Should Employers Take A Chance On Little-known Embarc To Pay For Gene Therapy?

      Nov 12, 2019

      Curing deadly diseases by administering a one-time therapy that rewrites a patient's genetic code is no longer the stuff of science fiction. Paying for it won't be easy.

      3 min read

    Reviews for Antiprotozoal Drug Discovery

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words